Case number 1:20-cv-01395
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 22, 2021 | 10 | SO ORDERED (3) Docket Text: SO ORDERED, re [9] Stipulation of Dismissal filed by Warner-Lambert Company LLC, Pfizer Inc., PF Prism IMB B.V., ***Civil Case Terminated. Signed by Judge Colm F. Connolly on 2/22/2021. (fms) |
| Feb 22, 2021 | 11 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,723,730 B2. (Attachments: # (1) Stipulation)(fms) |
| Feb 22, 2021 | 11 | Stipulation (3) |
| Feb 19, 2021 | 9 | Stipulation of Dismissal (3) Docket Text: STIPULATION of Dismissal by PF Prism IMB B.V., Pfizer Inc., Warner-Lambert Company LLC. (Dellinger, Megan) |
| Feb 5, 2021 | 8 | Letter (3) Docket Text: Letter to The Honorable Colm F. Connolly from Megan E. Dellinger regarding Request for Scheduling Conference. (Dellinger, Megan) |
| Dec 17, 2020 | 7 | Order (4) Docket Text: ORDER, on or before February 5, 2021, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 2/5/2021.) Signed by Judge Colm F. Connolly on 12/17/2020. Associated Cases: 1:20-cv-01392-CFC et al.(nmf) |
| Oct 21, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:20-cv-01392-UNA, 1:20-cv-01393-UNA, 1:20-cv-01395-UNA, 1:20-cv-01396-UNA(nms) |
| Oct 16, 2020 | 1 | Exhibit A (34) |
| Oct 16, 2020 | 1 | Civil Cover Sheet (1) |
| Oct 16, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd) |
| Oct 16, 2020 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: see attachment. Date of Expiration of Patent: 2/8/2034. (kmd) |
| Oct 16, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,723,730 B2. (kmd) |
| Oct 16, 2020 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for PF PRISM IMB B.V., Warner-Lambert Company LLC - filed by PF PRISM IMB B.V., Pfizer Inc., Warner-Lambert Company LLC. (kmd) |
| Oct 16, 2020 | 6 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (kmd) |
| Oct 16, 2020 | 1 | Complaint* (1) |
